Considering the development of liver stages in metabolically active hepatocytes and the robust activity of asparaginase utilized in ALL treatment22, 23, 45, supplemented asparagine may become insufficient and/or less accessible for liver stages. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.